Advanced Search

 

Study ID Status Title Patient Level Data
107017 Completed Multicentre study to assess the effect of prophylactic antipyretic treatment on the rate of febrile reactions following concomitant administration of GSK Biologicals’ 10-valent pneumococcal conjugate, Infanrix hexa and Rotarix vaccines Study Listed on ClinicalStudyDataRequest.com
107022 Completed A Study to Demonstrate the Non-Inferiority of Influenza Vaccine Candidate, Compared With Fluarix™ Administered Intramuscularly in Elderly Aged 60 Years Old and Above
107032 Completed An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Study Listed on ClinicalStudyDataRequest.com
107046 Completed To assess the safety, reactogenicity & immunogenicity of a 4th dose of GSK Biologicals’ pneumococcal vaccine or Prevenar™ in children (12-18 months) previously vaccinated in the primary study 105553 with either pneumococcal vaccine or Prevenar™ Study Listed on ClinicalStudyDataRequest.com
107058 Completed Evaluate immunogenicity, safety & reactogenicity of GSK Biologicals' 10-valent pneumococcal conjugate vaccine given as catch-up immunization in children older than 7 mo of age or as 3-dose primary immunization in children before 6 mo of age Study Listed on ClinicalStudyDataRequest.com
107064 Completed A phase III, observer-blind, randomised study to evaluate the safety and immunogenicity of one and two administrations of pandemic monovalent (H5N1) influenza vaccine (adjuvanted split virus formulation) in adults aged 18 years and older Study Listed on ClinicalStudyDataRequest.com
107066 Completed A phase II, randomized, open, controlled study to evaluate the safety and immunogenicity of different formulations of a pandemic influenza vaccine candidate (split virus formulation adjuvanted with AS03) given following a two-administration schedule (21 days apart) in children between 3 and 9 years of age. Study Listed on ClinicalStudyDataRequest.com
107070 Completed A phase III, double-blind, randomized, placebo-controlled, multi-country and multi-center study to assess the efficacy and safety of two doses of GSK Biologicals' oral live attenuated human rotavirus (HRV) vaccine in healthy infants. Study Listed on ClinicalStudyDataRequest.com
107077 Completed A study to assess the immunogenicity, reactogenicity and safety of 2 different formulations of GSK Biologicals' live attenuated HRV vaccine, given as a two-dose primary vaccination, in healthy infants previously uninfected with HRV Study Listed on ClinicalStudyDataRequest.com
107085 Completed A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin) Study Listed on ClinicalStudyDataRequest.com
107112 Completed A randomised, double-blind, two-way crossover study to investigate the effect of inhaled fluticasone furoate on short-term growth in paediatric subjects with asthma
107116 Not yet recruiting A randomised, double-blind, parallel group, multicentre, stratified, study evaluating the efficacy and safety of once daily fluticasone furoate/vilanterol inhalation powder compared to once daily fluticasone furoate inhalation powder in the treatment of asthma in participants aged 5 to 17 years old (inclusive) currently uncontrolled on inhaled corticosteroids
107118 Completed A randomized, double-blind, placebo-controlled, parallel group study of once-daily inhaled Fluticasone Furoate Inhalation Powder for six weeks on the hypothalamic-pituitary-adrenocortical axis of children aged 5-11 years with asthma
107137 Completed Prophylactic antipyretic treatment in children receiving booster dose of pneumococcal vaccine GSK1024850A and DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) and assessment of impact of pneumococcal vaccination on nasopharyngeal carriage Study Listed on ClinicalStudyDataRequest.com
107192 Completed Demonstrate the lot-to-lot consistency of 3 consecutive production lots of an adjuvanted influenza vaccine candidate and evaluate the safety of an adjuvanted influenza vaccine candidate versus Fluarix™ administered intramuscularly in elderly
107240 Terminated Cancer immunotherapeutic GSK1572932A as adjuvant therapy for patients with MAGE-A3-positive Non-Small Cell Lung cancer Study Listed on ClinicalStudyDataRequest.com
107291 Completed A phase IIIb, double-blind, randomized, controlled study to evaluate the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine, administered intramuscularly in healthy female subjects aged 15 – 25 years Study Listed on ClinicalStudyDataRequest.com
107336 Completed Safety and immunogenicity study of the HPV vaccine (GSK-580299) in healthy, Chinese, female subjects Study Listed on ClinicalStudyDataRequest.com
107386 Completed Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age) Study Listed on ClinicalStudyDataRequest.com
107408 Completed Immunogenicity & safety study of GSK Biologicals’ meningococcal vaccine GSK134612 administered in healthy subjects either previously primed with Mencevax™ ACWY or naïve to meningococcal vaccination. Study Listed on ClinicalStudyDataRequest.com
107457 Completed A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of BOTOX? (Botulinum Toxin Type A) in Subjects with Glabellar Lines
107476 (M18) Completed A long-term, open, follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1/AS04 vaccine in healthy female subjects vaccinated either pre- or post-menarche in the primary study
107495 Completed Reactogenicity and Immunogenicity Study of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1119711A) Administered According to Different Vaccination Schedules Study Listed on ClinicalStudyDataRequest.com
107507 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ (Influsplit SSW®) 2006/2007 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
107531 Completed Assess the immunogenicity of 3 doses of Pediarix®, Prevnar® & ActHIB® given to healthy infants when administered with GSK Biologicals’ 2 dose oral live attenuated human rotavirus vaccine given during the same vaccination visit or separately Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.